Alan Tackett
Concepts (605)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histones | 36 | 2025 | 315 | 5.720 |
Why?
| | Melanoma | 12 | 2024 | 272 | 3.880 |
Why?
| | Proteomics | 22 | 2025 | 332 | 3.550 |
Why?
| | Saccharomyces cerevisiae Proteins | 21 | 2019 | 132 | 3.430 |
Why?
| | Saccharomyces cerevisiae | 18 | 2019 | 168 | 2.730 |
Why?
| | Chromatin | 19 | 2025 | 143 | 2.600 |
Why?
| | Mass Spectrometry | 23 | 2021 | 294 | 2.510 |
Why?
| | Protein Processing, Post-Translational | 14 | 2020 | 152 | 2.060 |
Why?
| | Proteome | 12 | 2024 | 175 | 1.950 |
Why?
| | Chromosomal Proteins, Non-Histone | 8 | 2025 | 36 | 1.490 |
Why?
| | Protein Interaction Mapping | 4 | 2020 | 39 | 1.060 |
Why?
| | Nuclear Proteins | 7 | 2017 | 247 | 0.910 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2025 | 336 | 0.900 |
Why?
| | Skin Neoplasms | 4 | 2020 | 496 | 0.890 |
Why?
| | Lysine | 7 | 2025 | 90 | 0.890 |
Why?
| | Animals | 53 | 2025 | 13485 | 0.870 |
Why?
| | Histone Demethylases | 4 | 2014 | 18 | 0.850 |
Why?
| | Immunotherapy | 4 | 2021 | 251 | 0.840 |
Why?
| | Epigenesis, Genetic | 10 | 2025 | 396 | 0.830 |
Why?
| | Transcription Factors | 13 | 2025 | 570 | 0.820 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2023 | 224 | 0.820 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 86 | 0.800 |
Why?
| | Mice | 33 | 2023 | 5899 | 0.790 |
Why?
| | Melanoma, Experimental | 2 | 2021 | 34 | 0.760 |
Why?
| | Staphylococcus aureus | 6 | 2025 | 312 | 0.750 |
Why?
| | Bacterial Proteins | 7 | 2020 | 347 | 0.740 |
Why?
| | Gene Expression Regulation, Neoplastic | 11 | 2025 | 853 | 0.730 |
Why?
| | CTLA-4 Antigen | 2 | 2021 | 32 | 0.700 |
Why?
| | Cadherins | 2 | 2019 | 61 | 0.700 |
Why?
| | Histone Code | 2 | 2020 | 32 | 0.680 |
Why?
| | Neoplasms | 7 | 2021 | 1314 | 0.670 |
Why?
| | Cell Line, Tumor | 15 | 2025 | 1429 | 0.660 |
Why?
| | DNA-Binding Proteins | 9 | 2021 | 423 | 0.650 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 62 | 0.650 |
Why?
| | Genetic Loci | 3 | 2015 | 46 | 0.650 |
Why?
| | Neoplasms, Experimental | 1 | 2020 | 111 | 0.640 |
Why?
| | Gene Expression Regulation, Fungal | 5 | 2019 | 51 | 0.640 |
Why?
| | Protein Binding | 22 | 2025 | 673 | 0.630 |
Why?
| | Immunohistochemistry | 3 | 2020 | 977 | 0.620 |
Why?
| | Histone Acetyltransferases | 5 | 2014 | 25 | 0.610 |
Why?
| | Integrin alpha Chains | 1 | 2019 | 9 | 0.600 |
Why?
| | Arsenic | 1 | 2019 | 22 | 0.600 |
Why?
| | Cell Cycle Checkpoints | 1 | 2019 | 32 | 0.590 |
Why?
| | Humans | 62 | 2025 | 52441 | 0.590 |
Why?
| | Antibodies, Monoclonal | 2 | 2025 | 475 | 0.580 |
Why?
| | Gene Silencing | 5 | 2023 | 122 | 0.560 |
Why?
| | Apoptosis | 11 | 2023 | 1120 | 0.560 |
Why?
| | Antigens, CD | 1 | 2019 | 213 | 0.550 |
Why?
| | Lung Neoplasms | 2 | 2025 | 643 | 0.530 |
Why?
| | Immunologic Surveillance | 1 | 2017 | 10 | 0.530 |
Why?
| | Tumor Escape | 1 | 2017 | 18 | 0.530 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2017 | 46 | 0.520 |
Why?
| | Tumor Microenvironment | 5 | 2025 | 257 | 0.520 |
Why?
| | Blood Proteins | 1 | 2017 | 84 | 0.510 |
Why?
| | DNA Replication | 3 | 2025 | 159 | 0.500 |
Why?
| | Whole-Body Irradiation | 1 | 2017 | 128 | 0.500 |
Why?
| | Protein Kinase Inhibitors | 3 | 2025 | 231 | 0.500 |
Why?
| | Methylation | 11 | 2025 | 124 | 0.490 |
Why?
| | Chromatin Immunoprecipitation | 4 | 2012 | 48 | 0.490 |
Why?
| | Cell Cycle Proteins | 7 | 2025 | 168 | 0.480 |
Why?
| | Up-Regulation | 3 | 2018 | 462 | 0.480 |
Why?
| | Chromatography, Affinity | 2 | 2012 | 38 | 0.470 |
Why?
| | Nuclear Pore Complex Proteins | 3 | 2025 | 10 | 0.470 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2015 | 27 | 0.460 |
Why?
| | Space Flight | 3 | 2020 | 32 | 0.460 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2015 | 21 | 0.460 |
Why?
| | Chemical Fractionation | 1 | 2015 | 17 | 0.450 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2015 | 33 | 0.450 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2012 | 68 | 0.440 |
Why?
| | Antineoplastic Agents | 6 | 2023 | 1216 | 0.440 |
Why?
| | DNA | 6 | 2023 | 544 | 0.440 |
Why?
| | Repressor Proteins | 4 | 2019 | 150 | 0.440 |
Why?
| | Membrane Proteins | 2 | 2020 | 344 | 0.430 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 111 | 0.420 |
Why?
| | DNA Helicases | 6 | 2012 | 147 | 0.410 |
Why?
| | Staphylococcal Infections | 5 | 2025 | 270 | 0.410 |
Why?
| | Virulence Factors | 4 | 2020 | 78 | 0.400 |
Why?
| | Peptide Hydrolases | 3 | 2020 | 62 | 0.400 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2023 | 141 | 0.390 |
Why?
| | Pancreatic Neoplasms | 1 | 2015 | 208 | 0.390 |
Why?
| | Sepsis | 2 | 2025 | 236 | 0.380 |
Why?
| | Amino Acid Sequence | 11 | 2014 | 576 | 0.380 |
Why?
| | Nevus, Pigmented | 2 | 2012 | 34 | 0.370 |
Why?
| | T-Lymphocytes | 3 | 2020 | 318 | 0.370 |
Why?
| | Radiation, Ionizing | 3 | 2017 | 96 | 0.360 |
Why?
| | Epistasis, Genetic | 2 | 2009 | 29 | 0.360 |
Why?
| | Molecular Sequence Data | 10 | 2014 | 778 | 0.360 |
Why?
| | Promoter Regions, Genetic | 5 | 2023 | 465 | 0.360 |
Why?
| | Viral Nonstructural Proteins | 3 | 2008 | 61 | 0.350 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 2 | 2021 | 34 | 0.350 |
Why?
| | DNA Methylation | 5 | 2023 | 573 | 0.340 |
Why?
| | Cell Proliferation | 7 | 2023 | 1013 | 0.340 |
Why?
| | Oligonucleotides | 3 | 2008 | 76 | 0.340 |
Why?
| | Galactokinase | 3 | 2015 | 7 | 0.310 |
Why?
| | Chromosome Positioning | 1 | 2009 | 1 | 0.310 |
Why?
| | Exosomes | 2 | 2021 | 56 | 0.310 |
Why?
| | Oncogene Proteins, Fusion | 3 | 2025 | 61 | 0.310 |
Why?
| | Proteins | 2 | 2018 | 353 | 0.310 |
Why?
| | Disease Models, Animal | 7 | 2025 | 1483 | 0.300 |
Why?
| | Trans-Activators | 2 | 2020 | 137 | 0.300 |
Why?
| | Multiple Myeloma | 3 | 2023 | 3013 | 0.300 |
Why?
| | HEK293 Cells | 8 | 2025 | 236 | 0.300 |
Why?
| | Colonic Neoplasms | 2 | 2021 | 163 | 0.290 |
Why?
| | Blood Coagulation | 2 | 2025 | 64 | 0.290 |
Why?
| | Viral Proteins | 4 | 2009 | 164 | 0.290 |
Why?
| | Long Interspersed Nucleotide Elements | 3 | 2017 | 38 | 0.290 |
Why?
| | Formaldehyde | 3 | 2015 | 51 | 0.280 |
Why?
| | Chromatin Assembly and Disassembly | 4 | 2021 | 26 | 0.280 |
Why?
| | DNA, Single-Stranded | 3 | 2005 | 88 | 0.270 |
Why?
| | Bacterial Toxins | 2 | 2025 | 52 | 0.270 |
Why?
| | Brain Neoplasms | 2 | 2022 | 302 | 0.270 |
Why?
| | Neoplasm Proteins | 3 | 2016 | 328 | 0.260 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 3 | 2016 | 18 | 0.260 |
Why?
| | Neoplasm Metastasis | 3 | 2016 | 235 | 0.260 |
Why?
| | Virulence | 5 | 2020 | 160 | 0.260 |
Why?
| | Signal Transduction | 6 | 2025 | 1724 | 0.260 |
Why?
| | Homologous Recombination | 2 | 2018 | 44 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2020 | 198 | 0.250 |
Why?
| | Osteomyelitis | 2 | 2019 | 125 | 0.250 |
Why?
| | Acetylation | 8 | 2021 | 96 | 0.240 |
Why?
| | Protein Structure, Tertiary | 8 | 2014 | 260 | 0.240 |
Why?
| | Retroelements | 2 | 2023 | 13 | 0.240 |
Why?
| | Bacillus anthracis | 1 | 2025 | 14 | 0.240 |
Why?
| | Anthrax | 1 | 2025 | 9 | 0.240 |
Why?
| | Xenopus Proteins | 2 | 2019 | 34 | 0.240 |
Why?
| | Homeodomain Proteins | 3 | 2025 | 80 | 0.240 |
Why?
| | Brain Stem Neoplasms | 1 | 2025 | 7 | 0.240 |
Why?
| | Transcription, Genetic | 4 | 2009 | 375 | 0.240 |
Why?
| | Disease Progression | 5 | 2023 | 870 | 0.240 |
Why?
| | Factor XI | 1 | 2025 | 4 | 0.240 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 55 | 0.240 |
Why?
| | Gene Amplification | 1 | 2025 | 59 | 0.230 |
Why?
| | Oncogenes | 1 | 2025 | 61 | 0.230 |
Why?
| | Hepacivirus | 4 | 2008 | 103 | 0.230 |
Why?
| | Blood Coagulation Disorders | 1 | 2025 | 41 | 0.230 |
Why?
| | Nerve Tissue Proteins | 3 | 2019 | 201 | 0.230 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 17 | 0.230 |
Why?
| | Phosphorylation | 6 | 2017 | 536 | 0.220 |
Why?
| | Mice, Inbred C57BL | 9 | 2021 | 1888 | 0.220 |
Why?
| | Gene Expression Regulation, Bacterial | 5 | 2020 | 176 | 0.220 |
Why?
| | Glioma | 1 | 2025 | 83 | 0.220 |
Why?
| | Glycine | 1 | 2025 | 78 | 0.220 |
Why?
| | Proteolysis | 2 | 2022 | 100 | 0.220 |
Why?
| | Phenylalanine | 1 | 2025 | 139 | 0.210 |
Why?
| | Endothelial Cells | 3 | 2021 | 283 | 0.210 |
Why?
| | Endothelium, Vascular | 1 | 2025 | 263 | 0.210 |
Why?
| | Antigen Presentation | 1 | 2023 | 25 | 0.210 |
Why?
| | Endogenous Retroviruses | 1 | 2023 | 7 | 0.210 |
Why?
| | Tumor Cells, Cultured | 3 | 2021 | 441 | 0.210 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 230 | 0.210 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2022 | 132 | 0.200 |
Why?
| | Bacteriophage T4 | 4 | 2009 | 29 | 0.200 |
Why?
| | Polyporaceae | 1 | 2023 | 2 | 0.200 |
Why?
| | Time Factors | 6 | 2025 | 2987 | 0.200 |
Why?
| | Transcriptional Activation | 5 | 2025 | 127 | 0.200 |
Why?
| | Workflow | 2 | 2020 | 51 | 0.200 |
Why?
| | Methionine | 1 | 2024 | 142 | 0.190 |
Why?
| | Ikaros Transcription Factor | 1 | 2022 | 5 | 0.190 |
Why?
| | Weightlessness | 2 | 2020 | 13 | 0.190 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2023 | 147 | 0.190 |
Why?
| | High-Throughput Screening Assays | 2 | 2013 | 39 | 0.190 |
Why?
| | Breast Neoplasms | 3 | 2016 | 1203 | 0.190 |
Why?
| | Peptide Nucleic Acids | 1 | 2002 | 18 | 0.190 |
Why?
| | Cytochrome P-450 CYP2E1 | 2 | 2017 | 111 | 0.190 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2022 | 43 | 0.180 |
Why?
| | DNA Breaks, Double-Stranded | 3 | 2017 | 75 | 0.180 |
Why?
| | Cell Line | 7 | 2023 | 1020 | 0.180 |
Why?
| | Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 123 | 0.180 |
Why?
| | Phosphofructokinase-1, Type C | 1 | 2021 | 3 | 0.180 |
Why?
| | YY1 Transcription Factor | 1 | 2021 | 7 | 0.180 |
Why?
| | Spectrum Analysis, Raman | 1 | 2021 | 42 | 0.180 |
Why?
| | Fungal Proteins | 3 | 2018 | 114 | 0.180 |
Why?
| | Polycomb-Group Proteins | 1 | 2021 | 8 | 0.180 |
Why?
| | Ribonucleoproteins | 2 | 2019 | 23 | 0.180 |
Why?
| | Aging | 2 | 2016 | 722 | 0.170 |
Why?
| | Gene Expression Profiling | 3 | 2023 | 1099 | 0.170 |
Why?
| | Glioblastoma | 1 | 2022 | 89 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2021 | 23 | 0.170 |
Why?
| | Mutation | 8 | 2020 | 1331 | 0.170 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 83 | 0.170 |
Why?
| | Open Reading Frames | 4 | 2014 | 54 | 0.170 |
Why?
| | Blood-Brain Barrier | 1 | 2020 | 50 | 0.170 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2014 | 56 | 0.160 |
Why?
| | Cluster Analysis | 2 | 2019 | 236 | 0.160 |
Why?
| | Cells, Cultured | 5 | 2018 | 1583 | 0.160 |
Why?
| | Neovascularization, Pathologic | 1 | 2021 | 158 | 0.160 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2017 | 185 | 0.160 |
Why?
| | Nucleosomes | 4 | 2013 | 12 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 2 | 2021 | 180 | 0.160 |
Why?
| | Translocation, Genetic | 1 | 2021 | 266 | 0.160 |
Why?
| | Cell Cycle | 4 | 2019 | 236 | 0.160 |
Why?
| | Models, Molecular | 5 | 2013 | 356 | 0.160 |
Why?
| | Adaptation, Ocular | 1 | 2019 | 2 | 0.160 |
Why?
| | Blood-Retinal Barrier | 1 | 2019 | 6 | 0.150 |
Why?
| | Genome, Fungal | 3 | 2010 | 29 | 0.150 |
Why?
| | Malpractice | 1 | 2019 | 16 | 0.150 |
Why?
| | Poly(A)-Binding Proteins | 1 | 2019 | 6 | 0.150 |
Why?
| | Male | 17 | 2021 | 26874 | 0.150 |
Why?
| | Phosphoproteins | 1 | 2020 | 123 | 0.150 |
Why?
| | Arsenate Reductases | 1 | 2019 | 3 | 0.150 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 10 | 0.150 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2019 | 47 | 0.150 |
Why?
| | RNA-Binding Proteins | 3 | 2019 | 133 | 0.150 |
Why?
| | Protein Kinases | 1 | 2019 | 73 | 0.150 |
Why?
| | Chromatography, Liquid | 3 | 2020 | 245 | 0.150 |
Why?
| | Ruminococcus | 1 | 2019 | 7 | 0.150 |
Why?
| | Starch | 1 | 2019 | 12 | 0.150 |
Why?
| | Diagnostic Errors | 1 | 2019 | 69 | 0.150 |
Why?
| | Muscles | 2 | 2016 | 108 | 0.150 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2021 | 202 | 0.150 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 95 | 0.150 |
Why?
| | Membrane Transport Proteins | 1 | 2019 | 46 | 0.150 |
Why?
| | Cecum | 1 | 2019 | 56 | 0.150 |
Why?
| | Mutation Rate | 1 | 2018 | 36 | 0.150 |
Why?
| | Gravity, Altered | 1 | 2018 | 3 | 0.150 |
Why?
| | Oxidative Stress | 2 | 2020 | 805 | 0.150 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 146 | 0.140 |
Why?
| | Computational Biology | 1 | 2020 | 209 | 0.140 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 205 | 0.140 |
Why?
| | Adenosine | 1 | 2018 | 75 | 0.140 |
Why?
| | Chromans | 1 | 2018 | 34 | 0.140 |
Why?
| | Genomics | 2 | 2013 | 266 | 0.140 |
Why?
| | Transcriptional Elongation Factors | 2 | 2009 | 17 | 0.140 |
Why?
| | Retina | 1 | 2018 | 60 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 140 | 0.140 |
Why?
| | Models, Chemical | 3 | 2010 | 65 | 0.140 |
Why?
| | Software | 1 | 2020 | 281 | 0.140 |
Why?
| | Vitamin E | 1 | 2018 | 77 | 0.140 |
Why?
| | Kinetics | 5 | 2010 | 613 | 0.140 |
Why?
| | Scavenger Receptors, Class E | 1 | 2019 | 200 | 0.140 |
Why?
| | Spleen | 1 | 2018 | 166 | 0.140 |
Why?
| | Mentors | 1 | 2018 | 55 | 0.130 |
Why?
| | Gene Expression Regulation | 4 | 2019 | 1004 | 0.130 |
Why?
| | Interleukin-2 | 1 | 2017 | 69 | 0.130 |
Why?
| | Protein Biosynthesis | 3 | 2019 | 267 | 0.130 |
Why?
| | Cell Differentiation | 5 | 2021 | 667 | 0.130 |
Why?
| | Program Development | 1 | 2018 | 164 | 0.130 |
Why?
| | Radiation Injuries | 1 | 2018 | 114 | 0.130 |
Why?
| | Immunomodulation | 1 | 2017 | 36 | 0.130 |
Why?
| | Macaca mulatta | 1 | 2017 | 94 | 0.130 |
Why?
| | Muscle Development | 2 | 2014 | 24 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2020 | 1365 | 0.130 |
Why?
| | Universities | 1 | 2018 | 174 | 0.130 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2015 | 140 | 0.130 |
Why?
| | Gamma Rays | 1 | 2017 | 48 | 0.130 |
Why?
| | Tetrahymena thermophila | 2 | 2014 | 3 | 0.130 |
Why?
| | Mitochondria | 1 | 2020 | 420 | 0.130 |
Why?
| | Mitochondrial Proteins | 2 | 2018 | 91 | 0.130 |
Why?
| | Myocardial Infarction | 1 | 2021 | 449 | 0.130 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 161 | 0.130 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2017 | 56 | 0.130 |
Why?
| | 3' Untranslated Regions | 1 | 2016 | 54 | 0.130 |
Why?
| | Mitochondria, Liver | 1 | 2017 | 69 | 0.130 |
Why?
| | Myogenin | 2 | 2014 | 4 | 0.130 |
Why?
| | Alcohol Drinking | 1 | 2018 | 235 | 0.130 |
Why?
| | Biofilms | 4 | 2020 | 183 | 0.130 |
Why?
| | HeLa Cells | 4 | 2025 | 243 | 0.130 |
Why?
| | Butadienes | 1 | 2017 | 49 | 0.130 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 304 | 0.130 |
Why?
| | Calcineurin | 1 | 2017 | 77 | 0.130 |
Why?
| | Protozoan Proteins | 2 | 2014 | 33 | 0.120 |
Why?
| | Peptide Fragments | 3 | 2013 | 214 | 0.120 |
Why?
| | Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.120 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2016 | 12 | 0.120 |
Why?
| | Oocytes | 2 | 2019 | 95 | 0.120 |
Why?
| | Adenine | 1 | 2016 | 29 | 0.120 |
Why?
| | Cell Movement | 1 | 2017 | 271 | 0.120 |
Why?
| | Autoantigens | 1 | 2016 | 47 | 0.120 |
Why?
| | Ethanol | 1 | 2018 | 334 | 0.120 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 45 | 0.120 |
Why?
| | Tumor Burden | 1 | 2016 | 132 | 0.120 |
Why?
| | Kidney | 1 | 2020 | 716 | 0.120 |
Why?
| | Caenorhabditis elegans | 1 | 2016 | 135 | 0.120 |
Why?
| | Carcinogens | 1 | 2017 | 194 | 0.120 |
Why?
| | Papio | 2 | 2025 | 25 | 0.120 |
Why?
| | Epigenomics | 1 | 2016 | 75 | 0.120 |
Why?
| | Antigens, Viral | 1 | 2015 | 44 | 0.120 |
Why?
| | Rhadinovirus | 1 | 2015 | 22 | 0.120 |
Why?
| | Endoplasmic Reticulum | 1 | 2016 | 99 | 0.120 |
Why?
| | Macromolecular Substances | 2 | 2005 | 37 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-myb | 1 | 2015 | 8 | 0.120 |
Why?
| | Cell Survival | 5 | 2019 | 598 | 0.120 |
Why?
| | Chromosomes, Fungal | 2 | 2012 | 13 | 0.120 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2016 | 180 | 0.110 |
Why?
| | Mitosis | 2 | 2013 | 87 | 0.110 |
Why?
| | Curriculum | 1 | 2018 | 406 | 0.110 |
Why?
| | Collagen | 1 | 2016 | 215 | 0.110 |
Why?
| | Liver | 2 | 2018 | 1150 | 0.110 |
Why?
| | Heterochromatin | 1 | 2014 | 4 | 0.110 |
Why?
| | Carcinoma, Merkel Cell | 1 | 2015 | 41 | 0.110 |
Why?
| | Biomedical Research | 1 | 2018 | 260 | 0.110 |
Why?
| | Virus Replication | 1 | 2015 | 147 | 0.110 |
Why?
| | Hippocampus | 1 | 2016 | 231 | 0.110 |
Why?
| | Phenelzine | 1 | 2014 | 4 | 0.110 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 130 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 97 | 0.110 |
Why?
| | T-Box Domain Proteins | 1 | 2014 | 12 | 0.110 |
Why?
| | Rhabdomyosarcoma | 1 | 2014 | 12 | 0.110 |
Why?
| | Prognosis | 1 | 2019 | 2100 | 0.110 |
Why?
| | G-Quadruplexes | 1 | 2015 | 77 | 0.110 |
Why?
| | Threonine | 1 | 2013 | 15 | 0.110 |
Why?
| | Models, Biological | 3 | 2012 | 735 | 0.100 |
Why?
| | Heart | 1 | 2016 | 352 | 0.100 |
Why?
| | Enhancer Elements, Genetic | 3 | 2021 | 60 | 0.100 |
Why?
| | Female | 13 | 2021 | 28277 | 0.100 |
Why?
| | Sarcoma | 1 | 2014 | 68 | 0.100 |
Why?
| | Spheroids, Cellular | 2 | 2025 | 26 | 0.100 |
Why?
| | Parathyroid Hormone-Related Protein | 1 | 2013 | 20 | 0.100 |
Why?
| | Macaca | 1 | 2012 | 9 | 0.100 |
Why?
| | Methyltransferases | 2 | 2025 | 26 | 0.100 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2012 | 9 | 0.100 |
Why?
| | Treatment Outcome | 2 | 2020 | 5508 | 0.100 |
Why?
| | Sirtuin 1 | 1 | 2012 | 29 | 0.100 |
Why?
| | Indoles | 1 | 2015 | 283 | 0.100 |
Why?
| | DNA Repair Enzymes | 1 | 2012 | 42 | 0.090 |
Why?
| | Brain | 1 | 2020 | 1337 | 0.090 |
Why?
| | Alzheimer Disease | 1 | 2016 | 356 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-mos | 1 | 2012 | 8 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 378 | 0.090 |
Why?
| | gp100 Melanoma Antigen | 1 | 2011 | 8 | 0.090 |
Why?
| | Fixatives | 1 | 2011 | 12 | 0.090 |
Why?
| | Escherichia coli | 2 | 2014 | 182 | 0.090 |
Why?
| | Tissue Fixation | 1 | 2011 | 35 | 0.090 |
Why?
| | Paraffin Embedding | 1 | 2011 | 52 | 0.090 |
Why?
| | MAP Kinase Signaling System | 1 | 2012 | 128 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2021 | 903 | 0.090 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2023 | 187 | 0.090 |
Why?
| | Bone Neoplasms | 1 | 2013 | 188 | 0.090 |
Why?
| | Neurons | 1 | 2014 | 442 | 0.080 |
Why?
| | Hypertension | 1 | 2016 | 560 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2016 | 493 | 0.080 |
Why?
| | Diet, High-Fat | 1 | 2012 | 230 | 0.080 |
Why?
| | Hexosyltransferases | 1 | 2010 | 1 | 0.080 |
Why?
| | Maltose | 1 | 2010 | 3 | 0.080 |
Why?
| | Mycobacterium smegmatis | 1 | 2010 | 3 | 0.080 |
Why?
| | Substrate Specificity | 4 | 2015 | 197 | 0.080 |
Why?
| | Sugar Phosphates | 1 | 2010 | 3 | 0.080 |
Why?
| | Wnt Signaling Pathway | 2 | 2023 | 96 | 0.080 |
Why?
| | Trehalose | 1 | 2010 | 6 | 0.080 |
Why?
| | Glycogen | 1 | 2010 | 44 | 0.080 |
Why?
| | Movement | 1 | 2010 | 83 | 0.080 |
Why?
| | Chromatography | 2 | 2008 | 11 | 0.080 |
Why?
| | Adenosine Triphosphatases | 3 | 2008 | 91 | 0.080 |
Why?
| | Peptides | 2 | 2013 | 239 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2019 | 1134 | 0.080 |
Why?
| | Protein Stability | 2 | 2020 | 45 | 0.080 |
Why?
| | DNA Repair | 3 | 2017 | 194 | 0.070 |
Why?
| | Molecular Chaperones | 1 | 2009 | 76 | 0.070 |
Why?
| | Peptide Mapping | 1 | 2008 | 25 | 0.070 |
Why?
| | Histone Deacetylases | 2 | 2023 | 50 | 0.070 |
Why?
| | Microtubules | 1 | 2008 | 34 | 0.070 |
Why?
| | Sequence Alignment | 3 | 2014 | 121 | 0.070 |
Why?
| | Mice, SCID | 2 | 2021 | 178 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2009 | 177 | 0.070 |
Why?
| | RNA Helicases | 1 | 2008 | 29 | 0.070 |
Why?
| | bcl-2-Associated X Protein | 1 | 2008 | 58 | 0.070 |
Why?
| | bcl-X Protein | 1 | 2008 | 53 | 0.070 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2008 | 11 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 204 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 218 | 0.070 |
Why?
| | Recombinant Proteins | 3 | 2018 | 490 | 0.070 |
Why?
| | Rats | 3 | 2019 | 3228 | 0.070 |
Why?
| | Sequence Analysis, Protein | 1 | 2006 | 19 | 0.060 |
Why?
| | Tandem Mass Spectrometry | 2 | 2018 | 255 | 0.060 |
Why?
| | Binding Sites | 3 | 2014 | 379 | 0.060 |
Why?
| | MCF-7 Cells | 2 | 2016 | 63 | 0.060 |
Why?
| | Flow Cytometry | 1 | 2008 | 396 | 0.060 |
Why?
| | Gene Knockdown Techniques | 2 | 2016 | 110 | 0.060 |
Why?
| | E1A-Associated p300 Protein | 1 | 2006 | 9 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2021 | 100 | 0.060 |
Why?
| | Meiosis | 2 | 2018 | 70 | 0.060 |
Why?
| | Reactive Oxygen Species | 2 | 2018 | 415 | 0.060 |
Why?
| | Nuclear Pore | 1 | 2005 | 1 | 0.060 |
Why?
| | Xenopus laevis | 2 | 2019 | 44 | 0.060 |
Why?
| | RNA Interference | 2 | 2016 | 183 | 0.060 |
Why?
| | Staphylococcal Protein A | 1 | 2005 | 5 | 0.060 |
Why?
| | Osteoclasts | 2 | 2020 | 423 | 0.060 |
Why?
| | Trypsin | 1 | 2005 | 12 | 0.060 |
Why?
| | DNA Polymerase II | 1 | 2005 | 9 | 0.060 |
Why?
| | Complement Activation | 1 | 2025 | 27 | 0.060 |
Why?
| | Osteoblasts | 2 | 2020 | 478 | 0.060 |
Why?
| | Papio anubis | 1 | 2025 | 5 | 0.060 |
Why?
| | Phenotype | 2 | 2020 | 792 | 0.060 |
Why?
| | Origin Recognition Complex | 1 | 2025 | 6 | 0.060 |
Why?
| | Acetyltransferases | 1 | 2005 | 18 | 0.060 |
Why?
| | Replication Origin | 1 | 2025 | 11 | 0.060 |
Why?
| | Proto-Oncogenes | 1 | 2005 | 27 | 0.060 |
Why?
| | Stromal Cells | 1 | 2025 | 76 | 0.060 |
Why?
| | Protein Denaturation | 1 | 2005 | 16 | 0.060 |
Why?
| | Spectrometry, Fluorescence | 1 | 2005 | 46 | 0.060 |
Why?
| | Amino Acid Motifs | 2 | 2020 | 59 | 0.060 |
Why?
| | Inflammation Mediators | 1 | 2025 | 113 | 0.060 |
Why?
| | Neutrophils | 1 | 2025 | 148 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 140 | 0.050 |
Why?
| | RNA, Viral | 1 | 2005 | 123 | 0.050 |
Why?
| | Mammals | 2 | 2016 | 59 | 0.050 |
Why?
| | Mutation, Missense | 2 | 2018 | 108 | 0.050 |
Why?
| | Gene Deletion | 2 | 2015 | 279 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 10 | 0.050 |
Why?
| | S-Adenosylmethionine | 1 | 2024 | 62 | 0.050 |
Why?
| | Transfection | 2 | 2016 | 365 | 0.050 |
Why?
| | Major Histocompatibility Complex | 1 | 2023 | 13 | 0.050 |
Why?
| | RNA | 1 | 2005 | 174 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2005 | 412 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 38 | 0.050 |
Why?
| | MyoD Protein | 2 | 2014 | 8 | 0.050 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2023 | 47 | 0.050 |
Why?
| | Evolution, Molecular | 2 | 2016 | 98 | 0.050 |
Why?
| | Genome | 1 | 2023 | 61 | 0.050 |
Why?
| | Tamoxifen | 1 | 2023 | 60 | 0.050 |
Why?
| | HLA Antigens | 1 | 2023 | 55 | 0.050 |
Why?
| | Homocysteine | 1 | 2024 | 127 | 0.050 |
Why?
| | Mycelium | 1 | 2023 | 2 | 0.050 |
Why?
| | Trametes | 1 | 2023 | 3 | 0.050 |
Why?
| | Integrin beta Chains | 1 | 2023 | 14 | 0.050 |
Why?
| | Integrins | 1 | 2023 | 31 | 0.050 |
Why?
| | Young Adult | 3 | 2018 | 4346 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 1558 | 0.050 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2017 | 35 | 0.050 |
Why?
| | Cytogenetic Analysis | 1 | 2023 | 79 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 145 | 0.050 |
Why?
| | Monensin | 1 | 2022 | 7 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2023 | 355 | 0.050 |
Why?
| | Adult | 4 | 2022 | 14205 | 0.050 |
Why?
| | Fetus | 2 | 2014 | 191 | 0.050 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 2002 | 9 | 0.050 |
Why?
| | Simian virus 40 | 1 | 2002 | 12 | 0.050 |
Why?
| | Fluorescence Polarization | 1 | 2002 | 17 | 0.050 |
Why?
| | Organoids | 1 | 2022 | 35 | 0.050 |
Why?
| | Streptavidin | 1 | 2002 | 17 | 0.050 |
Why?
| | DNA, Viral | 1 | 2002 | 134 | 0.050 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2002 | 71 | 0.050 |
Why?
| | Blotting, Western | 2 | 2014 | 587 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2022 | 202 | 0.040 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2021 | 31 | 0.040 |
Why?
| | Cell Line, Transformed | 1 | 2021 | 74 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 70 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2020 | 29 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 40 | 0.040 |
Why?
| | Immunity, Cellular | 1 | 2020 | 64 | 0.040 |
Why?
| | Middle Aged | 4 | 2020 | 13133 | 0.040 |
Why?
| | Metalloendopeptidases | 1 | 2020 | 70 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 121 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 153 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2021 | 88 | 0.040 |
Why?
| | Radiotherapy | 1 | 2021 | 128 | 0.040 |
Why?
| | Cytoprotection | 1 | 2019 | 32 | 0.040 |
Why?
| | Heat-Shock Response | 1 | 2020 | 29 | 0.040 |
Why?
| | Databases, Genetic | 1 | 2020 | 82 | 0.040 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2019 | 6 | 0.040 |
Why?
| | Poly(A)-Binding Protein I | 1 | 2019 | 6 | 0.040 |
Why?
| | Aquaporin 4 | 1 | 2019 | 8 | 0.040 |
Why?
| | Oogenesis | 1 | 2019 | 19 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2019 | 26 | 0.040 |
Why?
| | Crystallins | 1 | 2019 | 11 | 0.040 |
Why?
| | Polyadenylation | 1 | 2019 | 21 | 0.040 |
Why?
| | Eye Proteins | 1 | 2019 | 16 | 0.040 |
Why?
| | Chromatography, Gel | 2 | 2010 | 40 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 632 | 0.040 |
Why?
| | Trihexosylceramides | 1 | 2018 | 2 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2019 | 61 | 0.040 |
Why?
| | Codon | 1 | 2018 | 42 | 0.040 |
Why?
| | Amino Acid Substitution | 2 | 2008 | 79 | 0.040 |
Why?
| | Bacteria | 1 | 2020 | 223 | 0.040 |
Why?
| | Retinal Pigment Epithelium | 1 | 2018 | 14 | 0.040 |
Why?
| | Actin Cytoskeleton | 1 | 2018 | 22 | 0.040 |
Why?
| | beta Catenin | 1 | 2018 | 105 | 0.040 |
Why?
| | Schizosaccharomyces | 1 | 2018 | 59 | 0.040 |
Why?
| | Autophagy | 1 | 2019 | 185 | 0.040 |
Why?
| | Protein Phosphatase 2 | 1 | 2017 | 4 | 0.030 |
Why?
| | Radiation-Protective Agents | 1 | 2018 | 69 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2018 | 182 | 0.030 |
Why?
| | Transcriptome | 1 | 2020 | 357 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 217 | 0.030 |
Why?
| | NFATC Transcription Factors | 1 | 2017 | 26 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 82 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2017 | 28 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2017 | 37 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 69 | 0.030 |
Why?
| | Electron Transport Complex III | 1 | 2017 | 6 | 0.030 |
Why?
| | Species Specificity | 1 | 2017 | 194 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2017 | 22 | 0.030 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2016 | 6 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2017 | 24 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2017 | 22 | 0.030 |
Why?
| | Ribonuclease III | 1 | 2016 | 14 | 0.030 |
Why?
| | Oligopeptides | 1 | 2017 | 94 | 0.030 |
Why?
| | Cyclin D1 | 1 | 2016 | 59 | 0.030 |
Why?
| | Intermediate Filament Proteins | 1 | 2016 | 12 | 0.030 |
Why?
| | Detergents | 1 | 2016 | 15 | 0.030 |
Why?
| | Operon | 1 | 2016 | 24 | 0.030 |
Why?
| | DEAD-box RNA Helicases | 1 | 2016 | 34 | 0.030 |
Why?
| | 14-3-3 Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | tau Proteins | 1 | 2016 | 31 | 0.030 |
Why?
| | Thiolester Hydrolases | 1 | 2016 | 5 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2017 | 116 | 0.030 |
Why?
| | Cyclophilins | 1 | 2016 | 9 | 0.030 |
Why?
| | Azacitidine | 1 | 2016 | 39 | 0.030 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2016 | 17 | 0.030 |
Why?
| | X Chromosome | 1 | 2016 | 13 | 0.030 |
Why?
| | DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 15 | 0.030 |
Why?
| | Hydroxylation | 1 | 2016 | 64 | 0.030 |
Why?
| | Solubility | 1 | 2016 | 81 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2016 | 91 | 0.030 |
Why?
| | Endopeptidases | 1 | 2016 | 62 | 0.030 |
Why?
| | Centrifugation | 1 | 2015 | 12 | 0.030 |
Why?
| | Ubiquitination | 1 | 2016 | 57 | 0.030 |
Why?
| | Osteogenesis Imperfecta | 1 | 2016 | 37 | 0.030 |
Why?
| | Cosmic Radiation | 1 | 2016 | 42 | 0.030 |
Why?
| | DNA, Mitochondrial | 1 | 2017 | 112 | 0.030 |
Why?
| | DNA Transposable Elements | 1 | 2016 | 107 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 175 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2015 | 28 | 0.030 |
Why?
| | Cell Death | 1 | 2016 | 169 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 59 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2016 | 50 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 230 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2016 | 116 | 0.030 |
Why?
| | Reference Values | 1 | 2016 | 316 | 0.030 |
Why?
| | DNA Damage | 1 | 2017 | 298 | 0.030 |
Why?
| | Isotope Labeling | 1 | 2015 | 59 | 0.030 |
Why?
| | Azepines | 1 | 2015 | 21 | 0.030 |
Why?
| | Gene Expression | 1 | 2017 | 618 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2016 | 83 | 0.030 |
Why?
| | Micronucleus, Germline | 1 | 2014 | 2 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1020 | 0.030 |
Why?
| | DNA, Protozoan | 1 | 2014 | 10 | 0.030 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2014 | 5 | 0.030 |
Why?
| | Genotype | 1 | 2016 | 563 | 0.030 |
Why?
| | Triazoles | 1 | 2015 | 115 | 0.030 |
Why?
| | Monoamine Oxidase | 1 | 2014 | 15 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 73 | 0.030 |
Why?
| | Plasmids | 1 | 2014 | 162 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2014 | 86 | 0.030 |
Why?
| | Antibody Specificity | 1 | 2013 | 36 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 230 | 0.030 |
Why?
| | Antibodies | 1 | 2013 | 144 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2013 | 35 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 1202 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2012 | 21 | 0.020 |
Why?
| | Animals, Outbred Strains | 1 | 2012 | 12 | 0.020 |
Why?
| | Thiazoles | 1 | 2013 | 53 | 0.020 |
Why?
| | p300-CBP Transcription Factors | 1 | 2012 | 6 | 0.020 |
Why?
| | Lung | 1 | 2016 | 479 | 0.020 |
Why?
| | Age Factors | 1 | 2016 | 1120 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2012 | 69 | 0.020 |
Why?
| | COS Cells | 1 | 2012 | 76 | 0.020 |
Why?
| | Acid Anhydride Hydrolases | 1 | 2012 | 14 | 0.020 |
Why?
| | Daptomycin | 1 | 2012 | 29 | 0.020 |
Why?
| | Catalytic Domain | 1 | 2012 | 61 | 0.020 |
Why?
| | Catheter-Related Infections | 1 | 2012 | 49 | 0.020 |
Why?
| | Drug Design | 1 | 2013 | 122 | 0.020 |
Why?
| | Bone and Bones | 1 | 2016 | 492 | 0.020 |
Why?
| | Arkansas | 1 | 2018 | 2013 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 146 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2012 | 146 | 0.020 |
Why?
| | Bacteremia | 1 | 2012 | 87 | 0.020 |
Why?
| | Microbial Sensitivity Tests | 1 | 2012 | 271 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 580 | 0.020 |
Why?
| | Aged | 2 | 2016 | 10242 | 0.020 |
Why?
| | S Phase | 1 | 2010 | 20 | 0.020 |
Why?
| | Glycogen Phosphorylase | 1 | 2010 | 2 | 0.020 |
Why?
| | Genes, Fungal | 1 | 2010 | 29 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 2010 | 22 | 0.020 |
Why?
| | Oligosaccharides | 1 | 2010 | 33 | 0.020 |
Why?
| | Rabbits | 1 | 2010 | 370 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2009 | 67 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2016 | 3449 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 27 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2008 | 23 | 0.020 |
Why?
| | Tubulin Modulators | 1 | 2008 | 28 | 0.020 |
Why?
| | Vincristine | 1 | 2008 | 89 | 0.020 |
Why?
| | Cohort Studies | 1 | 2013 | 1576 | 0.020 |
Why?
| | Nucleic Acid Denaturation | 1 | 2008 | 13 | 0.020 |
Why?
| | Scattering, Radiation | 1 | 2008 | 27 | 0.020 |
Why?
| | Cross-Linking Reagents | 1 | 2008 | 42 | 0.020 |
Why?
| | Light | 1 | 2008 | 50 | 0.020 |
Why?
| | Catalysis | 1 | 2008 | 88 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 799 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 33 | 0.020 |
Why?
| | Photoaffinity Labels | 1 | 2006 | 15 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 816 | 0.020 |
Why?
| | Peptide Initiation Factors | 1 | 2006 | 3 | 0.020 |
Why?
| | HMGB2 Protein | 1 | 2006 | 2 | 0.020 |
Why?
| | Acetyl Coenzyme A | 1 | 2006 | 5 | 0.020 |
Why?
| | Antigens, Nuclear | 1 | 2006 | 24 | 0.020 |
Why?
| | RNA Polymerase II | 1 | 2006 | 14 | 0.020 |
Why?
| | Xenopus | 1 | 2006 | 41 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2006 | 269 | 0.020 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2005 | 18 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2005 | 69 | 0.010 |
Why?
| | Telomere | 1 | 2005 | 39 | 0.010 |
Why?
| | Computer Simulation | 1 | 2006 | 285 | 0.010 |
Why?
| | Zinc Fingers | 1 | 2005 | 25 | 0.010 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2005 | 14 | 0.010 |
Why?
| | Microfilament Proteins | 1 | 2005 | 44 | 0.010 |
Why?
| | Multienzyme Complexes | 1 | 2005 | 43 | 0.010 |
Why?
| | Pregnancy | 1 | 2012 | 2642 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2006 | 871 | 0.010 |
Why?
| | Amino Acids | 1 | 2006 | 386 | 0.010 |
Why?
| | Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2003 | 1 | 0.010 |
Why?
| | Cyclin B | 1 | 2003 | 4 | 0.010 |
Why?
| | Oligodeoxyribonucleotides | 1 | 2002 | 29 | 0.010 |
Why?
| | Biotinylation | 1 | 2002 | 28 | 0.010 |
Why?
| | Biotin | 1 | 2002 | 46 | 0.010 |
Why?
|
|
Tackett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|